Artiva Biotherapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -28.72M-65.37M
Depreciation and Depletion 2.30M2.40M
Share-based Compensation 7.05M6.98M
Gains from Sales and Divestitures 0.02M
Gains from Investment Securities -0.14M0.15M
Non-cash Items 0.21M10.40M
Cash from Operations -47.43M-55.03M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.46M2.34M
Depreciation & Amortization (CF) 2.27M2.43M
Change in Working Capital
Change in Receivables 0.72M-1.03M
Change in Account Payables -0.41M0.52M
Change in Accured Expenses -0.91M-0.66M
Investing Activities
Capital Expenditures 3.26M0.64M
Change in Acquisitions & Divestments 26.80M56.35M
Cash from Investing Activities -25.98M-120.46M
Financing Activities
Other financing activities 4.18M
Change in Capital Stock
Shares Issued 0.01M166.51M
Misc.
Cash from Financing Activities 24.39M162.23M
Change in Cash -49.01M-13.27M
Free Cash Flow -50.69M-55.67M
Net Cash Flow -49.01M-13.27M